Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

eastman chemical co. - EMN

EMN

Close Chg Chg %
91.08 0.09 0.10%

Closed Market

91.17

+0.09 (0.10%)

Volume: 1.13M

Last Updated:

Mar 17, 2025, 3:59 PM EDT

Trade Now

Company Overview: eastman chemical co. - EMN

EMN Key Data

Open

$89.68

 Day Range

89.68 - 91.67

52 Week Range

86.71 - 114.50

 Market Cap

$10.49B

Shares Outstanding

115.17M

 Public Float

114.32M

Beta

1.45

 Rev. Per Employee

N/A

P/E Ratio

11.87

 EPS

$7.77

Yield

357.93%

 Dividend

$0.83

EX-DIVIDEND DATE

Mar 14, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

945.04K

  

EMN Performance

1 Week
 
 -7.80%
 
1 Month
 
 -9.83%
 
3 Months
 
 -0.74%
 
1 Year
 
 -1.32%
 
5 Years
 
 123.18%
 

EMN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About eastman chemical co. - EMN

Eastman Chemical Co. engages in the provision of specialty chemicals. It operates through the following segments: Advanced Material (AM), Additives and Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets its polymers, films, and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets. The AFP segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The CI segment consists of large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support operating segments with advantaged cost positions. The Fibers segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters. The company was founded by George Eastman in 1920 and is headquartered in Kingsport, TN.

EMN At a Glance

Eastman Chemical Co.
200 South Wilcox Drive
Kingsport, Tennessee 37662
Phone 1-800-327-8626 Revenue 9.37B
Industry Chemicals: Specialty Net Income 905.00M
Sector Process Industries 2024 Sales Growth 1.913%
Fiscal Year-end 12 / 2025 Employees 14,000
View SEC Filings

EMN Valuation

P/E Current 12.039
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.897
Price to Sales Ratio 1.149
Price to Book Ratio 1.819
Price to Cash Flow Ratio 8.366
Enterprise Value to EBITDA 8.184
Enterprise Value to Sales 1.618
Total Debt to Enterprise Value 0.34

EMN Efficiency

Revenue/Employee 669,571.429
Income Per Employee 64,642.857
Receivables Turnover 7.998
Total Asset Turnover 0.628

EMN Liquidity

Current Ratio 1.514
Quick Ratio 0.78
Cash Ratio 0.309

EMN Profitability

Gross Margin 24.856
Operating Margin 14.338
Pretax Margin 11.50
Net Margin 9.654
Return on Assets 6.064
Return on Equity 16.108
Return on Total Capital 8.272
Return on Invested Capital 8.905

EMN Capital Structure

Total Debt to Total Equity 89.323
Total Debt to Total Capital 47.18
Total Debt to Total Assets 33.932
Long-Term Debt to Equity 80.689
Long-Term Debt to Total Capital 42.62
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Eastman Chemical Co. - EMN

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
10.48B 10.54B 9.20B 9.37B
Sales Growth
+23.85% +0.50% -12.69% +1.91%
Cost of Goods Sold (COGS) incl D&A
7.96B 8.48B 7.14B 7.04B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
538.00M 477.00M 498.00M 509.00M
Depreciation
430.00M 390.00M 412.00M 427.00M
Amortization of Intangibles
108.00M 87.00M 86.00M 82.00M
COGS Growth
+23.32% +6.45% -15.84% -1.29%
Gross Income
2.52B 2.06B 2.06B 2.33B
Gross Income Growth
+25.59% -18.35% +0.29% +13.00%
Gross Profit Margin
+24.02% +19.52% +22.42% +24.86%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.05B 972.00M 966.00M 986.00M
Research & Development
254.00M 264.00M 239.00M 250.00M
Other SG&A
795.00M 708.00M 727.00M 736.00M
SGA Growth
+19.20% -7.34% -0.62% +2.07%
Other Operating Expense
- - - -
-
Unusual Expense
52.00M 81.00M 65.00M 73.00M
EBIT after Unusual Expense
1.42B 1.00B 1.03B 1.27B
Non Operating Income/Expense
(143.00M) 156.00M 278.00M 20.00M
Non-Operating Interest Income
3.00M 6.00M 10.00M 16.00M
Equity in Earnings of Affiliates
- 16.00M 19.00M 10.00M
Interest Expense
192.00M 182.00M 222.00M 213.00M
Interest Expense Growth
-6.34% -5.21% +21.98% -4.05%
Gross Interest Expense
197.00M 191.00M 240.00M 230.00M
Interest Capitalized
5.00M 9.00M 18.00M 17.00M
Pretax Income
1.08B 977.00M 1.09B 1.08B
Pretax Income Growth
+104.15% -9.70% +11.26% -0.83%
Pretax Margin
+10.32% +9.27% +11.82% +11.50%
Income Tax
215.00M 181.00M 191.00M 170.00M
Income Tax - Current - Domestic
138.00M 212.00M 140.00M 46.00M
Income Tax - Current - Foreign
115.00M 105.00M 153.00M 176.00M
Income Tax - Deferred - Domestic
4.00M (126.00M) (67.00M) (93.00M)
Income Tax - Deferred - Foreign
(42.00M) (10.00M) (35.00M) 41.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- 16.00M 19.00M 10.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
867.00M 796.00M 896.00M 908.00M
Minority Interest Expense
10.00M 3.00M 2.00M 3.00M
Net Income
857.00M 793.00M 894.00M 905.00M
Net Income Growth
+79.29% -7.47% +12.74% +1.23%
Net Margin Growth
+8.18% +7.53% +9.72% +9.65%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
857.00M 793.00M 894.00M 905.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
857.00M 793.00M 894.00M 905.00M
EPS (Basic)
6.3528 6.421 7.5379 7.7549
EPS (Basic) Growth
+80.08% +1.07% +17.39% +2.88%
Basic Shares Outstanding
134.90M 123.50M 118.60M 116.70M
EPS (Diluted)
6.2509 6.3491 7.4874 7.676
EPS (Diluted) Growth
+78.51% +1.57% +17.93% +2.52%
Diluted Shares Outstanding
137.10M 124.90M 119.40M 117.90M
EBITDA
2.01B 1.56B 1.59B 1.85B
EBITDA Growth
+18.13% -22.22% +2.11% +16.25%
EBITDA Margin
+19.15% +14.82% +17.33% +19.77%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 114.105
Number of Ratings 22 Current Quarters Estimate 1.904
FY Report Date 03 / 2025 Current Year's Estimate 8.482
Last Quarter’s Earnings 1.87 Median PE on CY Estimate N/A
Year Ago Earnings 7.89 Next Fiscal Year Estimate 9.458
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 17 19 18
Mean Estimate 1.90 2.24 8.48 9.46
High Estimates 1.98 2.40 8.75 10.20
Low Estimate 1.81 2.03 8.30 9.00
Coefficient of Variance 2.18 4.21 1.22 3.26

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 10 10 8
OVERWEIGHT 1 1 0
HOLD 11 11 14
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Eastman Chemical Co. - EMN

Date Name Shares Transaction Value
Mar 12, 2025 Brad A. Lich EVP & CCO 80,207 Bona fide gift 0.00
Mar 6, 2025 Michelle Caveness SVP & Chf. Mfg. Ofc. 2,314 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $83.84 per share 194,005.76
Mar 6, 2025 Michelle Caveness SVP & Chf. Mfg. Ofc. 1,167 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $98.51 per share 114,961.17
Mar 6, 2025 Michelle Caveness SVP & Chf. Mfg. Ofc. 1,148 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 3, 2025 Mark J. Costa CEO & Board Chair; Director 446,586 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.08 per share 44,694,326.88
Mar 3, 2025 Mark J. Costa CEO & Board Chair; Director 48,649 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 3, 2025 Mark J. Costa CEO & Board Chair; Director 451,420 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $65.16 per share 29,414,527.20
Feb 21, 2025 Michelle R. Stewart Controller & CAO 6,215 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Julie A. McAlindon SVP, Regions & Chf SupChn Ofcr 10,731 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 1,110,336.57
Feb 21, 2025 Julie A. McAlindon SVP, Regions & Chf SupChn Ofcr 12,808 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Stephen G. Crawford EVP-Methan. Ops & WWEC Transf. 64,097 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Christopher M. Killian SVP, CTO & Sust. Ofc, 24,248 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Stephen G. Crawford EVP-Methan. Ops & WWEC Transf. 58,912 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 6,095,624.64
Feb 21, 2025 Brian Travis Smith EVP, AFP, Mfg., WWEC & HSE 14,982 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 1,550,187.54
Feb 21, 2025 Adrian J. Holt SVP, Chf HR Ofcr 2,037 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 210,768.39
Feb 21, 2025 Adrian J. Holt SVP, Chf HR Ofcr 2,734 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 William T. McLain EVP, CFO 56,021 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Christopher M. Killian SVP, CTO & Sust. Ofc, 21,038 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 2,176,801.86
Feb 21, 2025 Brad A. Lich EVP & CCO 81,957 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.47 per share 8,480,090.79
Feb 21, 2025 Brian Travis Smith EVP, AFP, Mfg., WWEC & HSE 16,215 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Eastman Chemical Co. in the News